Opportunity Information: Apply for PAR 22 128

The NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed), funding opportunity number PAR-22-128, is a National Institutes of Health (NIH) grant run by the National Eye Institute (NEI) to help research teams prepare for major, multi-site, and other large-scale clinical vision studies. NEI funds substantial projects such as randomized clinical trials and epidemiologic studies, but those larger applications are expected to be highly detailed at the time they are submitted. In practice, that level of detail typically requires a carefully developed Manual of Procedures (MOP) that spells out exactly how the study will operate, from protocols to staffing to data handling. This program exists because producing that kind of manual and ironing out the operational details can be expensive and time-consuming, especially before a full-scale study is funded.

The core purpose of the R34 planning grant is to support the work that needs to happen before the definitive study starts. That includes refining the study rationale and design, tightening the analytic approach, clarifying and standardizing protocols and procedures, confirming the adequacy of facilities and research environment, and setting up the organizational structure and collaborative arrangements needed to run the eventual study. A central expected product is a well-documented MOP, which often includes items like eligibility criteria, recruitment and retention workflows, examination and imaging procedures, staff training and certification plans, visit schedules, adverse event reporting processes, quality assurance and quality control methods, data management procedures, and governance/communication plans across sites and partners.

In addition to writing and finalizing the MOP, the grant can support preliminary, non-interventional planning activities that reduce risk for the later full study. Examples described in the opportunity include preliminary studies used to refine study procedures or to document recruitment potential, such as testing screening workflows, evaluating the feasibility of proposed assessments, piloting data collection logistics, assessing site readiness, or confirming that the population of interest can be identified and enrolled at the expected pace. The key limitation is that this planning grant cannot be used to generate data on the effects of a proposed intervention. In other words, it is meant to prepare and de-risk a future clinical trial or epidemiologic study, not to run the intervention itself or produce outcomes that would substitute for a clinical efficacy or effectiveness evaluation.

Although the announcement references both epidemiologic and clinical trial research in terms of the types of large studies NEI supports, this specific R34 is explicitly "Clinical Trial Not Allowed." That means the planning activities must stay on the protocol-development and feasibility side rather than crossing into conducting a clinical trial under this award. Applicants should think of this mechanism as a bridge between a promising study concept and a later, fully powered, well-controlled NEI-funded study application, where the final protocol and operating playbook are already mature and ready for implementation.

Eligibility is broad and includes many types of domestic organizations and several special categories. Standard eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations (other than federally recognized tribal governments); public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses. The announcement also highlights additional eligible groups such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations), reflecting NEI's openness to a range of institutions that can contribute to vision research planning efforts.

Administratively, this is a discretionary grant in the health area (CFDA 93.867) with an award ceiling listed as $150,000. The opportunity was created on 2022-03-02 and lists an original closing date of 2025-05-07. Overall, the program is best understood as targeted support for the unglamorous but essential work of making a complex vision research study operationally ready: producing a rigorous Manual of Procedures, confirming feasibility, and strengthening the study plan so that a subsequent large-scale NEI application can be submitted with the level of detail and readiness NEI expects.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.867.
  • This funding opportunity was created on 2022-03-02.
  • Applicants must submit their applications by 2025-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $150,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 22 128

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: ERDC Broad Agency Announcement

Previous opportunity: Studies of Cytosolic DNAs in the Interactions of Aging Hallmarks (R01 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 22 128

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 22 128) also looked into and applied for these:

Funding Opportunity
Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional) Apply for PAR 22 122

Funding Number: PAR 22 122
Agency: National Institutes of Health
Category: Health
Funding Amount: $3,000,000
The Role of Dentistry in the Prevention of Opioid Drug Misuse and Abuse (UG3/UH3 Clinical Trial Optional) Apply for RFA DE 23 010

Funding Number: RFA DE 23 010
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed) Apply for PAR 22 119

Funding Number: PAR 22 119
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Advancing HIV/AIDS Research at the Intersection of Oral and Mental Health (R21 Clinical Trial Not Allowed) Apply for RFA DE 23 003

Funding Number: RFA DE 23 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Advancing HIV/AIDS Research at the Intersection of Oral and Mental Health (R01 Clinical Trial Not Allowed) Apply for RFA DE 23 002

Funding Number: RFA DE 23 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional) Apply for PAR 22 107

Funding Number: PAR 22 107
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54 Clinical Trial Not Allowed) Apply for RFA OD 22 003

Funding Number: RFA OD 22 003
Agency: National Institutes of Health
Category: Health
Funding Amount: $3,800,000
NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed) Apply for PAR 22 135

Funding Number: PAR 22 135
Agency: National Institutes of Health
Category: Health
Funding Amount: $150,000
Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54 Clinical Trial Optional) Apply for RFA OD 22 004

Funding Number: RFA OD 22 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $4,000,000
Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 22 022

Funding Number: RFA AI 22 022
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed) Apply for PAR 22 118

Funding Number: PAR 22 118
Agency: National Institutes of Health
Category: Health
Funding Amount: $230,000
Emergency Awards: Biocontainment Facility Improvements and Building System Upgrades to Support Pandemic Preparedness (G20 Clinical Trial Not Allowed) Apply for RFA AI 22 019

Funding Number: RFA AI 22 019
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional) Apply for PAR 22 104

Funding Number: PAR 22 104
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
International Bioethics Research Training Program (D43 Clinical Trial Optional) Apply for PAR 22 116

Funding Number: PAR 22 116
Agency: National Institutes of Health
Category: Health
Funding Amount: $230,000
NIA Program Project Applications (P01 Clinical Trial Optional) Apply for PAR 22 130

Funding Number: PAR 22 130
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Addressing Mental Health Disparities Research Gaps: Aggregating and Mining Existing Data Sets for Secondary Analyses (R01 Clinical Trial Not Allowed) Apply for RFA MH 22 200

Funding Number: RFA MH 22 200
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIAID Research Education Program (R25 Clinical Trial Not Allowed) Apply for PAR 22 134

Funding Number: PAR 22 134
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed) Apply for PAR 22 141

Funding Number: PAR 22 141
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Strengthening Integrated Health Services Activity (SIHSA) Apply for RFI 636 22 SIHSA 00001

Funding Number: RFI 636 22 SIHSA 00001
Agency: Guinea USAID-Conakry
Category: Health
Funding Amount: Case Dependent
Prospective Observational Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed) Apply for PAR 22 076

Funding Number: PAR 22 076
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 22 128", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: